v3.25.4
Consolidated Statement - Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Cash flows from operating activities:    
Net income (loss) $ (47,952) $ 3,687,416
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (7,293,022)
Changes in operating assets and liabilities:    
Note receivable (300,000)
Prepaid expenses (20,829) 2,808
Prepaid insurance (24,063)
Accounts payable and accrued expenses 33,366 193,587
Deferred legal fees 1,850,000
Net cash used in operating activities (35,415) (1,883,274)
Cash flows from investing activities:    
Investment of cash into Trust Account (190,000,000)
Cash withdrawn from Trust Account for working capital purposes 334,716
Net cash used in investing activities (189,665,284)
Cash flows from financing activities:    
Proceeds from issuance of founder shares 25,000
Proceeds from sale of Units, net of underwriting discounts paid 186,200,000
Proceeds from sale of Private Placement Units 6,900,000
Proceeds from promissory note - related party 76,790 33,203
Repayment of promissory note - related party (109,993)
Payment of deferred offering costs (46,370) (510,412)
Net cash provided by financing activities 55,420 192,512,798
Net change in cash 20,005 964,240
Cash, beginning of the period 20,005
Cash, end of the period 20,005 984,245
Noncash investing and financing activities:    
Deferred offering costs included in deferred legal fees 450,000 150,000
Deferred offering costs included in accrued offering costs 456,062
Deferred underwriting fee payable 7,600,000
Forfeiture of founder shares $ 38